CHCT:NYE-Community Healthcare Trust Incorporated (USD)

COMMON STOCK | REIT—Healthcare Facilities | NYE

Last Closing Price

USD 45.73

Change

0.00 (0.00)%

Market Cap

USD 1.01B

Volume

0.12M

Average Target Price

USD 42.38 (-7.34%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in non-urban markets throughout the United States. The Company had investments of approximately $641.9 million in 124 real estate properties as of March 31, 2020, located in 33 states, totaling approximately 2.7 million square feet. Additional information regarding the Company, including this quarter's operations, can be found at www.chct.reit.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-08-02 )

Largest Industry Peers for REIT—Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WELL Welltower Inc

N/A

USD22.36B 16.33 21.53
VTR Ventas, Inc

N/A

USD14.31B 16.96 12.46
MPW Medical Properties Trust, Inc

N/A

USD10.64B 25.10 19.55
OHI Omega Healthcare Investors, In..

N/A

USD7.35B 19.87 14.06
HTA Healthcare Trust of America, I..

N/A

USD6.03B 173.63 20.94
HR Healthcare Realty Trust Incorp..

N/A

USD3.95B 104.64 19.63
DOC Physicians Realty Trust

N/A

USD3.65B 45.10 17.33
NHI National Health Investors, Inc

N/A

USD2.77B 15.09 13.68
LTC LTC Properties, Inc

N/A

USD1.46B 12.47 18.19
GEO The GEO Group, Inc

N/A

USD1.29B 8.35 9.27

ETFs Containing CHCT

Symbol Name Weight Mer Price(Change) Market Cap
HYUP Xtrackers High Beta High .. 2.26 % 0.20 %

N/A

USD0.14B

Market Performance

  Market Performance vs.
Industry/Classification (REIT—Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.70% 100% A+ 83% B
Dividend Return 1.95% 36% F 72% C-
Total Return 8.65% 100% A+ 84% B
Trailing 12 Months  
Capital Gain 8.16% 86% B 78% C+
Dividend Return 3.93% 36% F 72% C-
Total Return 12.09% 86% B 80% B-
Trailing 5 Years  
Capital Gain 142.99% 100% A+ 93% A
Dividend Return 40.87% 100% A+ 93% A
Total Return 183.86% 100% A+ 95% A
Average Annual (5 Year Horizon)  
Capital Gain 23.69% 100% A+ 92% A-
Dividend Return 6.48% 75% C 87% B+
Total Return 30.17% 100% A+ 95% A
Risk Return Profile  
Volatility (Standard Deviation) 16.32% 75% C 47% F
Risk Adjusted Return 184.83% 100% A+ 98% A+
Market Capitalization 1.01B 29% F 56% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT—Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 92.65 36% F 6% F
Price/Book Ratio 2.74 15% F 28% F
Price / Cash Flow Ratio 31.32 7% F 8% F
EV/EBITDA 26.63 8% F 14% F
Management Effectiveness  
Return on Equity 3.46% 43% F 42% F
Return on Invested Capital 3.55% 36% F 35% F
Return on Assets 2.57% 57% F 55% F
Debt to Equity Ratio 54.96% 100% A+ 59% F
Technical Ratios  
Short Ratio 2.08 85% B 46% F
Short Percent 3.24% 62% D- 62% D-
Beta 0.61 71% C- 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector